Pharma exports from Gujarat grow exponentially

16 January 2017
drugs_pills_tablets_big

Pharmaceutical exports from the Indian state of Gujarat have crossed the $3 billion mark in the span of the last 10 years.

Gujarat features among the top pharmaceutical manufacturing hubs in India with an around 35% share in national production and 28% of pharmaceutical exports. The state has seen a six times increase in the growth of pharma exports in the last 10 years, notes a web posting by Brand India Pharma, an initiative led by Pharmexcil (Pharmaceutical Export Promotion Council) and IBEF (India Brand Equity Foundation) under the aegis of the Department of Commerce, India.

Pharma exports have increased from $562 million in 2006 to $3 billion in 2016. The state is home to more than 3,300 pharma manufacturing units, of which 255 are certified by the World Health Organization (WHO). 23 units are certified by Medicines and Healthcare Products Regulatory Agency certified by the UK government and 15 European Union certified units. The state also has 100 bulk drug manufacturing units and 135 licensed medical devices manufacturers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics